IL22 and fatty liver disease: In addition, orally delivered recombinant IL-22 by an engineered probiotic strain (i.e., Lactobacillus reuteri) was biologically active and resulted in reduced weight gain, and hepatic steatosis in mice fed a high-fat, high-sucrose diet [81].